Brief: Oryzon Completes Accelerated Bookbuild Offering At 2.70 Eur/Shr
BRIEF-Oryzon Completes Accelerated Bookbuild Offering At 2.70 Eur/Shr July 1 (Reuters) - Oryzon Genomics SA ORY.MC:
COMPLETED THE ACCELERATED BOOKBUILD OFFERING
EFFECTIVE AMOUNT OF THE CAPITAL INCREASE: 12.0 MILLION EUROS.
ISSUE PRICE: 2.70 EUROS PER SHARE, OF WHICH 0.05 EUROS CORRESPOND TO NOMINAL VALUE AND 2.65 EUROS TO SHARE PREMIUM.
ISSUE PRICE REPRESENTS A 12.68% DISCOUNT ON CLOSING PRICE OF COMPANY’S SHARES AS OF JUNE 30, 2026
NOMINAL AMOUNT OF THE CAPITAL INCREASE 222,222 EUROS
CAPITAL INCREASE REPRESENTS 5.56% BEFORE, 5.27% AFTER INCREASE
Source text: ID:nCNM7KWqNd
Further company coverage: ORY.MC
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on ORYZON Genomics SA
See all newsBrief: Oryzon Gets New Patent Grants For Vafidemstat In Four Countries
Brief: Oryzon Gets EMA Approval To Start Phase II Study Of Vafidemstat For PMS Treatment
Spanish stocks - Factors to watch on Aug 31
Brief: Oryzon Gets U.S. Patent Allowance For Iadademstat And Gilteritinib Drug Combo Application
Spanish stocks - Factors to watch on July 28